Drawing for TRANSCUTAN

USPTO serial 79364974

TRANSCUTAN

Reviewed by CopyMark Law Group

Reg. 7369765Status 700Registered
Filing date
Status date
Registration date
Apr 30, 2024
Examiner
MORRIS, KRISTINA KLOIBER
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TRANSCUTAN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alexander Lazouski

Alexander Lazouski LAZOUSKI IP LLCSUITE 1, 14726 BOWFIN TER.LAKEWOOD RANCH, FL 34202UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
010Medical and veterinary apparatus and instruments, namely, catheters; medical apparatus and instruments, namely, catheters; surgical apparatus and instruments; diagnostic, examination, and monitoring equipment, namely, blood pressure and diabetic diagnostic medical devices; diagnostic apparatus for medical purposes, namely, blood pressure and diabetic diagnostic medical devices; tools for medical diagnostics, namely, blood pressure and diabetic diagnostic medical devices; medical apparatus for preparing access to the bloodstream and gastrointestinal tract; medical apparatus for dosing drugs and nutrients to the bloodstream and gastrointestinal tract; valves for medical apparatus and instruments in the nature of biopsy valves; implantable medical apparatus and instruments, namely, subcutaneous valves comprised of artificial materials for implantation; catheter skin anchor medical instruments; medical devices for placing and securing cathetersACTIVE—
035Retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical goods; retail store services featuring medical apparatus; retail store services featuring medical instruments; business assistance, management and administration services; administrative support services in the nature of administrative processing of purchase orders and data processing services; data processing, systematization of data into computer databases, and database management; data processing services, namely, automatic processing of medical dataACTIVE—
042Scientific and technology services, namely, scientific research; scientific research and development; medical and pharmacological research services; design and development of medical diagnostic apparatus; research and development for the pharmaceutical industry; provision of information and data relating to medical and veterinary research and development; product testing, authentication of Medical and veterinary apparatus and instruments and quality control; testing the functionality of apparatus and instrumentsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 16, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 16, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 17, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 29, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 28, 2024FIMPFINAL DISPOSITION PROCESSED—
Jul 30, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 30, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Apr 30, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 14, 2024GPNXNOTIFICATION PROCESSED BY IB—
Feb 13, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 13, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 24, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 24, 2024OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 24, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 4, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 5, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 4, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 4, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 25, 2023RFNTREFUSAL PROCESSED BY IB—
Oct 2, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 2, 2023RFRRREFUSAL PROCESSED BY MPU—
Sep 20, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 19, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 6, 2023DOCKASSIGNED TO EXAMINER—
Mar 21, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 17, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 16, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance